source
- Survey finds most users find home diagnostic tests very helpful, but only a third view them as very accurateDet Norske Veritas (DNV) surveyed 12,500 people in 17 countries to gauge attitudes toward home diagnostic tests and other medical devices used at home. Among respondents who had used home diagnost…
- Sanofi secures first FDA approval to treat neurological symptoms in rare metabolic diseaseSanofi’s Infilbray is designed to cross the blood-brain barrier, allowing the drug to prevent the toxic buildup of disease-causing lipids in the brain for patients with type 3 Gaucher disease.BioSpace · 1d ago↗ source
- FDA approves Infilbray, first therapy for neurological symptoms of Type 3 Gaucher disease